Chemoinformaics analysis of 2-Methyl (1, 3, 4) oxadiazole
Molecular Weight | 453.344 | nRot | 4 |
Heavy Atom Molecular Weight | 432.176 | nRig | 27 |
Exact Molecular Weight | 452.096 | nRing | 5 |
Solubility: LogS | -4.336 | nHRing | 3 |
Solubility: LogP | 4.263 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 4 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 29 | No. of Aromatic Carbocycles | 2 |
nHetero | 8 | No. of Aromatic Hetero Cycles | 2 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 6 | No. of Arom Atom | 20 |
No. of Oxygen atom | 1 | No. of Arom Bond | 21 |
nHA | 7 | APOL | 59.5247 |
nHD | 0 | BPOL | 28.7433 |
QED | 0.457 |
Synth | 2.632 |
Natural Product Likeliness | -1.507 |
NR-PPAR-gamma | 0.012 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.586 |
Pgp-sub | 0.003 |
HIA | 0.006 |
CACO-2 | -4.749 |
MDCK | 0.0000247 |
BBB | 0.98 |
PPB | 0.955588 |
VDSS | 3.149 |
FU | 0.0552756 |
CYP1A2-inh | 0.52 |
CYP1A2-sub | 0.803 |
CYP2c19-inh | 0.952 |
CYP2c19-sub | 0.713 |
CYP2c9-inh | 0.907 |
CYP2c9-sub | 0.363 |
CYP2d6-inh | 0.891 |
CYP2d6-sub | 0.876 |
CYP3a4-inh | 0.831 |
CYP3a4-sub | 0.661 |
CL | 7.857 |
T12 | 0.022 |
hERG | 0.828 |
Ames | 0.026 |
ROA | 0.939 |
SkinSen | 0.141 |
Carcinogencity | 0.756 |
EI | 0.015 |
Respiratory | 0.945 |
NR-Aromatase | 0.055 |
Antiviral | Yes |
Prediction | 0.760437 |